Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Paclitaxel in Recurrent or Metastatic SCCHN
NCT00100789Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jan 2005
- Primary completion
- Feb 2008
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Paclitaxel Micelles for Injection in squamous cell carcinoma of the head and neck (HNSCC), sponsored by SWOG Cancer Research Network. Started Jan 2005; status: completed.
02
Drugs
gemcitabinePaclitaxel Micelles for Injection
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00100789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100789.